1. Home
  2. FRA vs CYRX Comparison

FRA vs CYRX Comparison

Compare FRA & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock Floating Rate Income Strategies Fund Inc

FRA

Blackrock Floating Rate Income Strategies Fund Inc

HOLD

Current Price

$11.08

Market Cap

415.1M

Sector

Finance

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$9.96

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRA
CYRX
Founded
2003
1999
Country
United States
United States
Employees
N/A
1100
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.1M
419.3M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
FRA
CYRX
Price
$11.08
$9.96
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$12.94
AVG Volume (30 Days)
153.2K
406.1K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
11.06%
N/A
EPS Growth
N/A
156.22
EPS
N/A
1.40
Revenue
N/A
$176,177,000.00
Revenue This Year
N/A
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
N/A
$6.89
Revenue Growth
N/A
N/A
52 Week Low
$10.50
$5.21
52 Week High
$13.41
$11.45

Technical Indicators

Market Signals
Indicator
FRA
CYRX
Relative Strength Index (RSI) 52.53 70.69
Support Level $10.54 $9.18
Resistance Level $11.80 $10.23
Average True Range (ATR) 0.15 0.42
MACD 0.05 0.19
Stochastic Oscillator 83.21 88.01

Price Performance

Historical Comparison
FRA
CYRX

About FRA Blackrock Floating Rate Income Strategies Fund Inc

Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: